U.S. Clinical Chemistry and Immunoassay Reagents Markets
18-Feb-2004
North America
Market Research
A726-01-00-00-00
HC00952-NA-MR_04805
Clinical diagnostic tests have long been used as a means of screening, diagnosing, and monitoring disease. Two common methods used in obtaining reportable results for clinical laboratory tests are clinical chemistry and immunoassay techniques. Clinical chemistry tests are analytical human biochemistry tests. Immunoassays, on the other hand, are tests that involve an antigen-antibody reaction. Both types of tests are run using various bodily fluids. It is estimated that over 7.2 billion reportable results were produced in laboratories in the US in 2003, 5.6 billion of which used clinical chemistry and immunoassay techniques and reagents.
Executive Summary
- Executive Summary
Market Overview
- Introduction
- Market Segmentation
- Market Snapshot
- Definitions
- Research Methodology
Market Dynamics
- Market Challenges
- Strategies
- Market Drivers
- Market Restraints
Unit and Demand Analysis
- End User Groups
- Unit and Demand Analysis
Pricing and Revenue Analysis
- Pricing Analysis
- Revenue Forecasts
Competitive Landscape and Trends
- Competitive Structure
- Market Share Analysis
- Market and Technology Trends
Market Overview
Unit and Demand Analysis
Pricing and Revenue Analysis
Competitive Environment
Market Overview
Unit and Demand Analysis
Pricing Revenue and Competitive Analysis
Competitive Environment
Frost & Sullivan Awards
Decision Support Databases
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.